proses analisa
tematik didapatkan
enam tema
yang sama pada
pasien yaitu: (1)
Pengetahuan
tentang kemoterapi,
(2) efek samping
kemoterapi, (3)
koping individu, (4)
dukungan keluarga,
(5) kinerja perawat
dan
(6) harapan terhadap
perawat
2. Faqih Indonesia Studi diskriptif kuantitatif Desain studi ini Partisipan dipilih Rata rata usia Perubahan lain
Ruhyanudin1), terhadap 50 pasien yang adalah denganteknik partisipan adalah yang terjadi
Agung menjalani kemoterapi di desainkualitatif purposive 47,8 tahun dengan pada mayoritas
Waluyo2), Northeast dengan pendekatan samplingdan partisipan termuda partisipan
Yulia2) Poland didapatkan fenomenologi untuk menggunakan berusia 36 tahun dan adalah
mengalami efek samping memperoleh prinsip saturasi yang tertua berusia terjadinya
asthenia, kehilangan perasa, gambaran tentang data. 53 tahun. penurunan
mual, dan muntah. pengalaman pasien Kriteriainklusi: Berdasarkan latar kenyamanan
Kemudian sekitar 54% kanker yang (1) belakang fisik,
pasien tidak bekerja selama menjalani pasien yang telah tempat tinggal ketidakstabilan
pengobatan, 74% kemoterapi meliputi terdiagnosis partisipan mayoritas emosional dan
mengalami gangguan aspek bio-psiko- kanker dan bertempat tinggal di gangguan
aktivitas sehari-hari sedang sosio-spiritual. sedang menjalani wilayah Jabotabek hubungan
sampai berat, sehingga kemoterapi,(2) yaitu sebanyak 5 interpersonal di
berpengaruh buruk pada bersedia menjadi orang. Berdasarkan tempat kerja.
Tabel Elaborasi
Matsuhashi2, chemotherapy clinic and to the outpatient 2014; among although there was outpatient
Takao determine risk factors for chemotherapy clinic. these, a marked difference cancer
Takahashi, nausea. A checklist for chemotherapy in the control of chemotherapy
Kazuhiro adverse events was was carried out in CINV among HEC, clinic. In
Yoshida2 provided to all 8206 visits, as mentioned earlier. spite of the high
Yoshinori patients, and nausea thereby indicating The low rate of the rate of
Itoh1 and vomiting were a 14.4 % control of CINV adherence to the
monitored on the discontinuance for antiemetic
next visit. Complete rate. The actual cyclophosphamide- guideline,
protection from number of base regimens may the control of
nausea and vomiting patients counted be caused by the nausea, but not
during acute (within by the patient ID patient risks (female vomiting, was
24 h) anddelayed number was 779 and young age) poor in
(during 2–7 days) and the number of rather than the patients
periods was assessed. chemotherapy chemotherapy, receiving HEC
cycles was 5577. because the and MEC. A
Health cyclophosphamide- multivariate
professionals such base regimens logistic
as pharmacists were used for the regression
and nurses were most part in breast analysis
in charge of cancer patients, indicated that
provision of whose female gender,
drug information average age was 48 age under
and safety years. 60 years,
precaution in HEC/MEC, and
daily life and of A/C
monitoring chemotherapy
adverse drug were significant
reactions to all risks for overall
patients in our nausea. Care
Tabel Elaborasi